Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies · Industry: Medical Instruments & Supplies · Exchange: Nasdaq
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Headquarters: Toowong, QLD · Employees: 174 · Website: https://anteristech.com
Anteris Technologies Global Corp. (AVR) is a publicly traded company in the Orthopedic, Prosthetic & Surgical Appliances & Supplies sector (Medical Instruments & Supplies), listed on Nasdaq. Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.
Macroplane tracks Anteris Technologies Global Corp.'s (AVR) supply chain. Key suppliers include AT&T INC. (T), Accton Technology Corp. (2345.TW), NVIDIA CORP (NVDA), Nebius Group N.V. (NBIS).
Search companies · Macro trends · Industries · Product categories · Baskets